Page Ahead

Page Ahead is an AI-native biotechnology company specializing in the generative design of novel proteins. The company leverages advanced machine learning models, including protein language models, to engineer biological molecules with optimized therapeutic and industrial properties. Founded by Namrata Anand, a pioneer in the development of the ESM protein language models at Meta AI, Page Ahead aims to transition protein engineering from stochastic discovery to intentional design. Their platform integrates deep learning architectures with high-throughput experimental workflows to navigate the vast fitness landscape of protein sequences. By accelerating the creation of antibodies, enzymes, and other protein-based modalities, the company seeks to address significant unmet needs in human health and biotechnology.